Published in Cancer Chemother Pharmacol on January 01, 1990
Reporting results of cancer treatment. Cancer (1981) 28.83
Young age as a prognostic factor in cervical cancer: analysis of population based data from 10,022 cases. Br Med J (Clin Res Ed) (1988) 1.73
Ifosfamide in experimental tumor systems. Semin Oncol (1982) 1.47
Prediction of ifosfamide/mesna associated encephalopathy. Eur J Cancer Clin Oncol (1986) 1.20
Phase II study of ifosfamide in cervical cancer. Cancer Treat Rep (1986) 1.09
Cervical carcinoma: a drug-responsive tumor--experience with combined cisplatin, vinblastine, and bleomycin therapy. Gynecol Oncol (1983) 1.02
Ifosfamide--current aspects and perspectives. Cancer Treat Rev (1983) 1.01
The anticancer spectrum of ifosfamide. Semin Oncol (1982) 0.98
A phase II study of ifosfamide in advanced and relapsed carcinoma of the cervix. Cancer Chemother Pharmacol (1986) 0.92
Perspectives on research in gynecologic oncology. Cancer (1976) 0.86
Medical treatment of advanced carcinoma of the cervix. A review. Tumori (1977) 0.79
Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial. Lancet (2001) 5.75
Lifespan of human lymphocyte subsets defined by CD45 isoforms. Nature (1992) 4.86
Mitomycin, ifosfamide, and cisplatin in unresectable non-small-cell lung cancer: effects on survival and quality of life. J Clin Oncol (1999) 3.20
Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial. Ann Surg (2001) 2.94
Factors associated with childhood cancer in a national cohort study. Br J Cancer (1990) 2.86
Newer concepts of the pathophysiology of hiatal hernia and esophagitis. Am J Surg (1966) 2.48
Clinical importance of analysing malignant tumours of uncertain origin with immunohistological techniques. Lancet (1985) 2.40
HPV 16 DNA in normal and malignant cervical epithelium: implications for the aetiology and behaviour of cervical neoplasia. Lancet (1987) 2.38
Randomised trial of two regimens of chemotherapy in operable osteosarcoma: a study of the European Osteosarcoma Intergroup. Lancet (1997) 2.33
Patients with cancer holding their own records: a randomised controlled trial. Br J Gen Pract (2000) 2.09
Changes in rheumatology out-patient workload over 12 years in the South West of England. Rheumatology (Oxford) (2003) 2.02
Treatment for children with brain tumours. BMJ (1995) 2.01
Loop diathermy excision of the cervical transformation zone in patients with abnormal cervical smears. BMJ (1990) 1.91
Hypoxia-regulated carbonic anhydrase IX expression is associated with poor survival in patients with invasive breast cancer. Br J Cancer (2007) 1.84
A comparison of two short intensive adjuvant chemotherapy regimens in operable osteosarcoma of limbs in children and young adults: the first study of the European Osteosarcoma Intergroup. J Clin Oncol (1992) 1.79
Ifosfamide-containing chemotherapy in Ewing's sarcoma: The Second United Kingdom Children's Cancer Study Group and the Medical Research Council Ewing's Tumor Study. J Clin Oncol (1998) 1.66
Cat admissions to RSPCA shelters in Queensland, Australia: description of cats and risk factors for euthanasia after entry. Aust Vet J (2013) 1.64
Identification and in vitro expansion of functional antigen-specific CD25+ FoxP3+ regulatory T cells in hepatitis C virus infection. J Virol (2008) 1.63
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Nonsurgical management of acute jejunal diverticulitis: a review. Am J Gastroenterol (1997) 1.56
Is stage I epithelial ovarian cancer overtreated both surgically and systemically? Results of a five-year cancer registry review. Br J Obstet Gynaecol (1992) 1.47
Parent comprehension of polio vaccine information pamphlets. Pediatrics (1996) 1.44
Groin recurrence following Stage 1A squamous cell carcinoma of the vulva. Gynecol Oncol (2005) 1.42
Human papillomavirus type-16 homologous DNA in normal human ectocervix. Lancet (1986) 1.42
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41
Results of randomised studies of the EORTC Soft Tissue and Bone Sarcoma Group (STBSG) with two different ifosfamide regimens in first- and second-line chemotherapy in advanced soft tissue sarcoma patients. Eur J Cancer (2002) 1.41
Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7 TeV. Phys Rev Lett (2011) 1.39
Management of malignant phaeochromocytoma: a retrospective review of the use of MIBG and chemotherapy in the West Midlands. Clin Oncol (R Coll Radiol) (2001) 1.38
Prebiopsy neo-adjuvant endocrine therapy for breast cancer to prevent post-surgery trauma-induced growth factor and immune-suppression mediated tumour progression. Eur J Cancer (1996) 1.38
Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32
Identification of a sequence containing the positive regulatory region of Saccharomyces cerevisiae gene ENO1. Gene (1986) 1.32
Enhanced cell killing in lewis lung carcinoma and a human pancreatic-carcinoma xenograft by the combination of cytotoxic drugs and misonidazole. Br J Cancer (1981) 1.23
Validity and community utility of the Canadian Occupational Performance Measure. Can J Occup Ther (2000) 1.21
A phase I/II study of gemcitabine and fractionated cisplatin in an outpatient setting using a 21-day schedule in patients with advanced and metastatic bladder cancer. Br J Cancer (2004) 1.21
Prediction of ifosfamide/mesna associated encephalopathy. Eur J Cancer Clin Oncol (1986) 1.20
Reexamination of series relationships of South American wild potatoes (Solanaceae: Solanum sect. Petota): evidence from chloroplast DNA restriction site variation. Am J Bot (1997) 1.17
Encephalopathy associated with ifosphamide/mesna therapy. Lancet (1985) 1.17
Safety, pharmacokinetics, and antiretroviral activity of the potent, specific human immunodeficiency virus protease inhibitor nelfinavir: results of a phase I/II trial and extended follow-up in patients infected with human immunodeficiency virus. J Clin Pharmacol (1998) 1.16
Risk of malignancy index for referral of ovarian cancer cases to a tertiary center: does it identify the correct cases? Int J Gynecol Cancer (2006) 1.16
Osteosarcoma of the pelvis. J Bone Joint Surg Br (1999) 1.16
Recurrent squamous cell carcinoma of the vulva: a study of 73 cases. Gynecol Oncol (1993) 1.15
Detection of human papillomavirus DNA in biopsies of human oral tissue. Br J Cancer (1987) 1.15
A novel signal transduction cascade in capacitating human spermatozoa characterised by a redox-regulated, cAMP-mediated induction of tyrosine phosphorylation. J Cell Sci (1998) 1.14
Association between high-risk HPV types, HLA DRB1* and DQB1* alleles and cervical cancer in British women. Br J Cancer (2000) 1.14
Giant cell tumour of the sacrum: a suggested algorithm for treatment. Eur Spine J (2010) 1.10
The differential diagnosis of routinely processed anaplastic tumors using monoclonal antibodies. Am J Clin Pathol (1984) 1.09
Phase II study of ifosfamide in cervical cancer. Cancer Treat Rep (1986) 1.09
Changing character of cervical cancer in young women. BMJ (1989) 1.09
Combination of bleomycin and mitomycin after failure of cisplatin and alkylating agent therapy in epithelial ovarian cancer. Cancer Treat Rep (1986) 1.08
An examination of the renal transplant evaluation process focusing on cost and the reasons for patient exclusion. Am J Kidney Dis (1998) 1.06
More radiotherapists, please. BMJ (1991) 1.06
A randomised controlled trial of the caries-preventive efficacy of a chlorhexidine-containing varnish in high-caries-risk adolescents. Caries Res (2000) 1.04
Prognostic factors and metastatic patterns in primary myxoid/round-cell liposarcoma. Sarcoma (2011) 1.04
Patterns of relapse in glioblastoma multiforme following concomitant chemoradiotherapy with temozolomide. Br J Radiol (2013) 1.04
Primary bone lymphoma--treatment and outcome. Clin Oncol (R Coll Radiol) (2007) 1.04
Iron uptake and regulation of ferritin synthesis by hepatoma cells in hormone-supplemented serum-free media. J Biol Chem (1983) 1.04
Huntington disease phenocopy is a familial prion disease. Am J Hum Genet (2001) 1.04
In the queue for coronary artery bypass grafting: patients' perceptions of risk and 'maximal acceptable waiting time'. J Health Serv Res Policy (1999) 1.03
Biochemical, molecular and behavioral phenotypes of Rab3A mutations in the mouse. Genes Brain Behav (2007) 1.02
Collapse of morphological species in the wild potato Solanum brevicaule complex (Solanaceae: sect. Petota). Am J Bot (1998) 1.02
Chemotherapy for breast cancer (Review). Oncol Rep (2010) 1.01
Early serum CA125 response and outcome in epithelial ovarian cancer. Eur J Cancer (1990) 1.01
Conservative treatment for girls with nonmetastatic rhabdomyosarcoma of the genital tract: A report from the Study Committee of the International Society of Pediatric Oncology. J Clin Oncol (1999) 1.00
Combination bleomycin, ifosfamide, and cisplatin chemotherapy in cervical cancer. J Natl Cancer Inst (1989) 1.00
Redox regulation of tyrosine phosphorylation in human spermatozoa and its role in the control of human sperm function. J Cell Sci (1995) 0.99
Chemoradiotherapy with or without induction chemotherapy for locally advanced pancreatic cancer: a UK multi-institutional experience. Clin Oncol (R Coll Radiol) (2010) 0.98
Loosening of the femoral component after total hip replacement. The thin black line and the sinking hip. J Bone Joint Surg Br (1986) 0.97
Peritoneal trauma releases CA125? Br J Cancer (1988) 0.97
Uncompensated hospital care: charitable mission or profitable business decision? Health Econ (1997) 0.95
A reappraisal of the causes of hemoptysis. Arch Intern Med (1991) 0.94
Nucleotide sequence of the 5' flanking region responsible for the enhancement of the expression of yeast enolase 1 gene. J Biochem (1985) 0.93
Intravascular leiomyomatosis and benign metastasizing leiomyoma: an unusual case. Int J Gynecol Cancer (2006) 0.93
Standardized exercise oximetry predicts postpneumonectomy outcome. Ann Thorac Surg (1997) 0.92
MR imaging of multiple sclerosis: comparison with clinical and CT examinations in 74 patients. AJR Am J Roentgenol (1985) 0.92
Case report: primary subcutaneous sacrococcygeal ependymoma: a case report and review of the literature. Br J Radiol (2006) 0.92
Outcome of children with posterior fossa medulloblastoma: a single institution experience over the decade 1994-2003. Childs Nerv Syst (2006) 0.91
Evaluating the marginal student: a workshop for clinical faculty. J Allied Health (1998) 0.91
The cost effectiveness of auranofin: results of a randomized clinical trial. J Rheumatol (1988) 0.90
Local therapy and other factors influencing site of relapse in patients with localised Ewing's sarcoma. United Kingdom Children's Cancer Study Group (UKCCSG). Eur J Cancer (1999) 0.90
Oriented immobilisation of engineered single-chain antibodies to develop biosensors for virus detection. J Virol Methods (2006) 0.89
An ultrasound window to perform scanned, focused ultrasound hyperthermia treatments of brain tumors. Med Phys (1987) 0.89
Role of extracorporeal shock-wave lithotripsy in treatment of urolithiasis in patients with medullary sponge kidney. Urology (1993) 0.88
The effect of cytotoxic drugs with or without misonidazole on leucopenia in three strains of mice. Int J Radiat Oncol Biol Phys (1982) 0.88
Identification and treatment of anaemia in patients awaiting hip replacement. Ann R Coll Surg Engl (2008) 0.87
A novel deletion mutation within the carboxyl terminus of the copper-transporting ATPase gene causes Wilson disease. J Neurol Sci (2000) 0.87
Spontaneous regression of metastatic malignant melanoma of the parotid gland and neck lymph nodes: a case report and a review of the literature. Clin Oncol (R Coll Radiol) (2001) 0.86
Measurement of the ZZ production cross section and limits on anomalous neutral triple gauge couplings in proton-proton collisions at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 0.86